Atlas Trials

A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled ZT-111 in Patients With Metastatic Prostate Cancer

Clinical trial NCT06201741 · UNKNOWN

Trial details

NCT number
NCT06201741
Sponsor
Huashan Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Prostate Specific Membrane Antigen Positive Metastatic Prostate Cancer
Start date
2023-12-27
Primary completion
2024-04-30
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.